Home

Download

Statistics

Examples

Help

Contact

Editing gene: SLC9A7P1 (CAeditome ID:121456)

Gene summary for SLC9A7P1

Gene summary

Gene information	Gene symbol	SLC9A7P1
	Gene ID	121456
	Gene name	solute carrier family 9 member 7 pseudogene 1
	Synonyms	-
	Cytomap	12q23.1
	Type of gene	pseudo
	Description	solute carrier family 9 (sodium/hydrogen exchanger), member 7 pseudogene 1solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7 pseudogene 1
	Modification date	20210518
	UniProtAcc	.
	Context

Gene ontology of each this gene with evidence of Inferred from Direct Assay (IDA) from Entrez

Gene

GO ID

GO term

PubMed ID

Top

RNA A-to-I events for SLC9A7P1

RNA A-to-I editing events across TCGA 33 cancers data sets based on Ensembl gene isoform structure.

RNA editing frequencies across 33 cancers of gene: ENSG00000227825.4

RNA A-to-I editing events in Cancer.

CAediting_916087(98453891, -), CAediting_916088(98453905, -), CAediting_916089(98453906, -), CAediting_916090(98453921, -), CAediting_916091(98453922, -), CAediting_916092(98453924, -), CAediting_916093(98453951, -), CAediting_916094(98453955, -), CAediting_916095(98453956, -), CAediting_916096(98453970, -), CAediting_916097(98453976, -), CAediting_916098(98453987, -), CAediting_916099(98453996, -), CAediting_916100(98453997, -), CAediting_916101(98454002, -), CAediting_916102(98454005, -), CAediting_916103(98454022, -), CAediting_916104(98454025, -), CAediting_916105(98454028, -), CAediting_916106(98454031, -), CAediting_916107(98454033, -), CAediting_916108(98454034, -), CAediting_916109(98454036, -), CAediting_916110(98454037, -), CAediting_916111(98454041, -), CAediting_916112(98454052, -), CAediting_916113(98454062, -), CAediting_916114(98454077, -), CAediting_916115(98454078, -), CAediting_916116(98454091, -), CAediting_916117(98454126, -), CAediting_916118(98454131, -), CAediting_916119(98454132, -), CAediting_916120(98454140, -),

Top

RNA editing positional annotations for SLC9A7P1 using Annovar

Protein coding RNA editing(s).

CAeditome ID

Position

Variant type

ENST

NTchange

AAchange

SIFT_score

Polyphen2_HVAR_score

PROVEAN_pred

Gene structure information of RNA editing(s).

CAeditome ID	Position	Variant type
CAediting_916087	chr12_98453891_-	ncRNA_exonic
CAediting_916088	chr12_98453905_-	ncRNA_exonic
CAediting_916089	chr12_98453906_-	ncRNA_exonic
CAediting_916090	chr12_98453921_-	ncRNA_exonic
CAediting_916091	chr12_98453922_-	ncRNA_exonic
CAediting_916092	chr12_98453924_-	ncRNA_exonic
CAediting_916093	chr12_98453951_-	ncRNA_exonic
CAediting_916094	chr12_98453955_-	ncRNA_exonic
CAediting_916095	chr12_98453956_-	ncRNA_exonic
CAediting_916096	chr12_98453970_-	ncRNA_exonic
CAediting_916097	chr12_98453976_-	ncRNA_exonic
CAediting_916098	chr12_98453987_-	ncRNA_exonic
CAediting_916099	chr12_98453996_-	ncRNA_exonic
CAediting_916100	chr12_98453997_-	ncRNA_exonic
CAediting_916101	chr12_98454002_-	ncRNA_exonic
CAediting_916102	chr12_98454005_-	ncRNA_exonic
CAediting_916103	chr12_98454022_-	ncRNA_exonic
CAediting_916104	chr12_98454025_-	ncRNA_exonic
CAediting_916105	chr12_98454028_-	ncRNA_exonic
CAediting_916106	chr12_98454031_-	ncRNA_exonic
CAediting_916107	chr12_98454033_-	ncRNA_exonic
CAediting_916108	chr12_98454034_-	ncRNA_exonic
CAediting_916109	chr12_98454036_-	ncRNA_exonic
CAediting_916110	chr12_98454037_-	ncRNA_exonic
CAediting_916111	chr12_98454041_-	ncRNA_exonic
CAediting_916112	chr12_98454052_-	ncRNA_exonic
CAediting_916113	chr12_98454062_-	ncRNA_exonic
CAediting_916114	chr12_98454077_-	ncRNA_exonic
CAediting_916115	chr12_98454078_-	ncRNA_exonic
CAediting_916116	chr12_98454091_-	ncRNA_exonic
CAediting_916117	chr12_98454126_-	ncRNA_exonic
CAediting_916118	chr12_98454131_-	ncRNA_exonic
CAediting_916119	chr12_98454132_-	ncRNA_exonic
CAediting_916120	chr12_98454140_-	ncRNA_exonic

Repat-regional RNA editing(s).

CAeditome ID	Position	Repeat family	Repeat sub family	Repeat name
CAediting_916087	chr12_98453891_-	SINE	Alu	AluSq
CAediting_916088	chr12_98453905_-	SINE	Alu	AluSq
CAediting_916089	chr12_98453906_-	SINE	Alu	AluSq
CAediting_916090	chr12_98453921_-	SINE	Alu	AluSq
CAediting_916091	chr12_98453922_-	SINE	Alu	AluSq
CAediting_916092	chr12_98453924_-	SINE	Alu	AluSq
CAediting_916093	chr12_98453951_-	SINE	Alu	AluSq
CAediting_916094	chr12_98453955_-	SINE	Alu	AluSq
CAediting_916095	chr12_98453956_-	SINE	Alu	AluSq
CAediting_916096	chr12_98453970_-	SINE	Alu	AluSq
CAediting_916097	chr12_98453976_-	SINE	Alu	AluSq
CAediting_916098	chr12_98453987_-	SINE	Alu	AluSq
CAediting_916099	chr12_98453996_-	SINE	Alu	AluSq
CAediting_916100	chr12_98453997_-	SINE	Alu	AluSq
CAediting_916101	chr12_98454002_-	SINE	Alu	AluSq
CAediting_916102	chr12_98454005_-	SINE	Alu	AluSq
CAediting_916103	chr12_98454022_-	SINE	Alu	AluSq
CAediting_916104	chr12_98454025_-	SINE	Alu	AluSq
CAediting_916105	chr12_98454028_-	SINE	Alu	AluSq
CAediting_916106	chr12_98454031_-	SINE	Alu	AluSq
CAediting_916107	chr12_98454033_-	SINE	Alu	AluSq
CAediting_916108	chr12_98454034_-	SINE	Alu	AluSq
CAediting_916109	chr12_98454036_-	SINE	Alu	AluSq
CAediting_916110	chr12_98454037_-	SINE	Alu	AluSq
CAediting_916111	chr12_98454041_-	SINE	Alu	AluSq
CAediting_916112	chr12_98454052_-	SINE	Alu	AluSq
CAediting_916113	chr12_98454062_-	SINE	Alu	AluSq
CAediting_916114	chr12_98454077_-	SINE	Alu	AluSq
CAediting_916115	chr12_98454078_-	SINE	Alu	AluSq
CAediting_916116	chr12_98454091_-	SINE	Alu	AluSq
CAediting_916117	chr12_98454126_-	SINE	Alu	AluSq
CAediting_916118	chr12_98454131_-	SINE	Alu	AluSq
CAediting_916119	chr12_98454132_-	SINE	Alu	AluSq
CAediting_916120	chr12_98454140_-	SINE	Alu	AluSq

Top

RNA A-to-I editing events in the alternative splicing sites for SLC9A7P1

RNA A-to-I editing(s) in the alternative splicing sites.

AStype

CAeditomID

Editing position

AS position

AS direction

Exonic location

Wildtype sequence

Wildtype splicing strength

RNA edited sequence

RNA edited splicing strength

Differential percent of spliced in (PSI) between RNA A-to-I edited and non-edited samples for ENSG00000227825.4.SLC9A7P1.

Correlation between RNA A-to-I editing and PSI for ENSG00000227825.4.SLC9A7P1.

Top

Differntial gene expression between RNA A-to-I edited versus non-edited samples for SLC9A7P1

Differential gene expressions between RNA A-to-I edited and non-edited tumor samples.
* The grey color means N/A.

Correlation between RNA A-to-I editing and gene expression.

- Differentially expressed gene between RNA A-to-I edited samples versus non-edited samples.
* Click on the image to enlarge it in a new window.

Top

Protein coding region RNA A-to-I editings for SLC9A7P1

- Lollipop plot for RNA A-to-I editings across protein structure.
* Click on the image to enlarge it in a new window.

Top

The effects of the RNA editing to the miRNA binding sites for SLC9A7P1

**If you are searching a miRNA gene with RNA editing events in its seed regions, please see the search pages of miRNA targets to discover the effects of this RNA editing event to miRNA regulations. For more information, please check the files in the Download page.

RNA A-to-I editing in the 3'-UTR regions of mRNA gained miRNA binding sites.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in the 3'-UTR regions of mRNA lost miRNA binding sites.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in lncRNA gained miRNA binding sites.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in lncRNA lost miRNA binding sites.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in miRNAs gained binding to lncRNA.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in miRNAs lost binding to lncRNA.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in miRNAs gained binding to the 3'-UTR region of mRNA.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

RNA A-to-I editing in miRNAs lost binding to the 3'-UTR mRNA.

CAeditom_ID

Position

ENSG

ENST

miRNA

Targetscan start

Targetscan end

Targetscan score

Miranda start

Miranda end

Miranda score

Miranda energy

Differentially expressed gene-miRNA network

Top

The effects of the RNA editing to the stability of the RNA structures for SLC9A7P1

- RNA A-to-I editing in mRNA.
* Click on the image to enlarge it in a new window.

ENST

ENST type

RNA structure without RNA A-to-I editing.

RNA structure with RNA A-to-I editing.

RNA A-to-I editing in RNA structures for Minimum free energy (MFE).

CAeditom_ID

ENST

Editing_Position

MFE_withoneAI

MFE_withoutAI

MFE_withmultipleAI

Top

Relation with ADAR for SLC9A7P1

Correlation between ADAR gene expression and RNA editing frequency

Cancer

CAeditomID

position

ADAR1 (p-val)

ADAR1 (coeff.)

ADAR2 (p-val)

ADAR2 (coeff.)

ADAR3 (p-val)

ADAR3 (coeff.)

Top

Relation with cancer stages for SLC9A7P1

Correlation between Cancer stages and RNA editing frequency

Cancer

Stage_type

CAeditomID

position

P-val

Coeff.

Top

Relation with survival for SLC9A7P1

Correlation between RNA editing and survival

Cancer

CAeditomID

position

KMpvalue

Coxpvalue

CoxHR

Top

RelatedDrugs for SLC9A7P1

Approved drugs targeting this gene.
(DrugBank Version 5.1.8 2021-01-03)

Gene

UniProtAcc

DrugBank ID

Drug name

Drug activity

Drug type

Drug status

Top

RelatedDiseases for SLC9A7P1

Diseases associated with this gene.
(DisGeNet 7.0)

Gene

Disease ID

Disease name

# pubmeds

Source

	Gene summary
	RNA A-to-I events
	Differntial gene expression between RNA A-to-I edited tumor samples versus normal samples
	Protein coding region RNA A-to-I editings
	The effects of the RNA editing to the miRNA binding sites
	The effects of the RNA editing to the stability of the RNA structures
	Relation with ADAR
	Relation with cancer stages
	Relation with survival state
	Related drugs with this gene
	Related diseases with this gene